Retatrutide plateau and possible adaptation or resistance

That lines up with what I'm doing since I combine both of them at once.

Weight has been creeping back up slowly, yet I still feel somewhat more in control than before reta. It is working a little, just nowhere near the first few months. From my lowest point I want to drop another 18 lb, which would put me 30 lb above where I am now. 170 would be ideal but 180 is probably a realistic target for a muscular lean look.

Start low and go slow with teso as well since you are already on 12 mg reta. The nine-day half-life means it takes time to reach steady state and even longer to clear if heart rate rises. Check heart rate and blood pressure daily.

Me too, I stack that.

I do not usually see much point in separating the two except for the psychological lessons that can keep people occupied until the medication takes hold, such as using smaller plates or finding dopamine elsewhere. Things get more complicated once you factor in the intracellular signaling differences.

Much of the receptor data comes from theory or animal work rather than human studies, and many online summaries are inaccurate. Binding numbers do not tell the whole story because most of the drug is albumin-bound and different drugs can trigger different intracellular pathways. Tirzepatide, for example, biases toward cAMP signaling at the GLP-1 receptor, giving stronger overall GLP-1 effects and fewer side effects despite lower binding affinity. Receptor internalization is also reduced. Tirzepatide remains the strongest GIP agonist, has solid GLP-1 activity, and 15 mg may exceed the GLP-1 effect of 2.4 mg sema in practice.

Thanks for the reply.

Thanks for the insight.

Cagri tends to lose effect faster than the GLPs in anecdotal reports, which may explain why it is not used more for stacking. I personally get more GI sides than most, yet the differences among the GLP drugs feel small to me. I have tried all of them except one. I rarely get nausea but can get diarrhea, heartburn, gas or bloating from any of them. Some of those effects at 10 mg tirz are still memorable months later. At 1 mg, sema was tolerable. I cannot go above 6 mg tirz weekly without issues. Survo and reta have not caused problematic heart-rate or sleep effects so far.

I stacked sema with reta only because I was reluctant to stop sema after it finally removed food noise for the first time. I wanted to test reta's other benefits so I added it while keeping 2.5 mg sema. Once reta reached 8 mg I developed what felt like morning sickness and stopped the sema. A month later the nausea is gone and food noise remains controlled, though some sema is probably still in my system.

I do not understand why people expect very low doses to keep working. Twenty pounds is roughly 5-10 % loss, which is typical for that dose range. Unless side effects are an issue there is little reason not to raise the dose once weight loss stops. For significant obesity the standard target is the full 12 mg dose to reduce long-term health risks.

Same issue here. Did you notice any change at 3 mg? I have been on 2 mg for four weeks and plan to go to 3 mg on Monday.

If the higher dose is improving appetite control then scale movement should follow. Going from 188 lb to 125 lb is a 33 % reduction. Average responders in the best reta study lost about 29 % at 12 mg over roughly a year, so reaching your goal is plausible at the full dose but unlikely if you stay low. At your age and starting weight metabolic syndrome is probable; checking blood pressure, glucose and lipids would be useful. Full-dose reta is likely to lower risks of diabetes, heart disease and stroke.

Ditto. There is no "soon enough."

Do people actually use those? I tried one before and my appetite became enormous. Is that typical with the others?

One of the ghrelin agonists can strongly increase appetite, but the more common ones like tesa do not. I have been able to eat less on hexarelin and HGH simply because the routine supports fasting. I was stuck at 200 lb for months but weight is moving again now. Intermittent fasting helped even before any GLP use.

Unless you are an unusually strong responder the effect is dose-dependent, so higher doses produce more weight loss. Why not follow the trial schedule of doubling every four weeks? The studies show clear results that way.

I began at the study dose of 2 mg and it hit hard with no appetite, poor sleep and constipation. Food noise has started returning in the last week and a half, so I am going up by only 1 mg hoping for fewer side effects than the initial jump.

This is exactly when slow titration makes sense. If side effects appear at low doses, waiting for them to ease and then adding only 1 mg at a time is the right approach. Splitting doses can also help if sides are brief. When no side effects occur there is less reason to stay very low or increase extremely slowly.

There are two classes. GHRH agonists such as tesamorelin or sermorelin have only modest appetite effects and tend to be weight-neutral because growth hormone also raises energy expenditure. The ghrelin-receptor agonists like MK-677, GHRP-2 or ipamorelin directly stimulate hunger. Claims that ipamorelin avoids this usually come from people using tiny doses; at clinical-trial amounts the appetite increase is clear.

Thanks for the clear explanation. That is really interesting and I had no idea.

From what I have seen with tirz and reta you need to allow time for levels to stabilize. Moving from 2 mg to 5 mg for only two weeks is not long enough to reach steady therapeutic concentrations. Four weeks is a better minimum. I am currently switching from tirz to reta, titrating reta up while lowering tirz, with injections three days apart. Keeping a small tirz dose helps control food noise until reta levels are adequate.

You need to remain at any given dose for at least four weeks before judging its effect.